Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alissa Thomas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Headache|January 25, 2012
Teaching case: severe headache in a leukemicAlissa Thomas
Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 6, 2024
Rare dual-genotype IDH mutant glioma: Review of previously reported cases and two new cases of true "oligoastrocytoma"Isabella Sutherland, John DeWitt, Alissa Thomas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Reply to M.C. Chamberlain and T.J. KruserClaire F Verschraegen, Alissa Thomas, Vincent Vinh-Hung
World Neurosurgery|August 24, 2019
Disseminated Rosette-Forming Glioneuronal Tumor with Spinal Drop Metastasis, a Uniquely Aggressive Presentation of Rare TumorLuke Silveira, John DeWitt, Alissa Thomas, et al.
Leukemia & Lymphoma|June 7, 2026
Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosisDermot J Murphy, Siba El Hussein, Angela Applebee, et al.
CNS Oncology|February 2, 2018
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumabAlissa Thomas, Marc Rosenblum, Sasan Karimi, et al.
JAMA Neurology|October 30, 2013
Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapyAlissa Thomas, Paula Rauschkolb, Núria Gresa-Arribas, et al.
Neuro-Oncology|November 6, 2015
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patientsMyron Zhang, Bryanna Gulotta, Alissa Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Headache|January 25, 2012
Teaching case: severe headache in a leukemicAlissa Thomas
Neuropathology : Official Journal of the Japanese Society of Neuropathology|April 6, 2024
Rare dual-genotype IDH mutant glioma: Review of previously reported cases and two new cases of true "oligoastrocytoma"Isabella Sutherland, John DeWitt, Alissa Thomas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Reply to M.C. Chamberlain and T.J. KruserClaire F Verschraegen, Alissa Thomas, Vincent Vinh-Hung
World Neurosurgery|August 24, 2019
Disseminated Rosette-Forming Glioneuronal Tumor with Spinal Drop Metastasis, a Uniquely Aggressive Presentation of Rare TumorLuke Silveira, John DeWitt, Alissa Thomas, et al.
Leukemia & Lymphoma|June 7, 2026
Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosisDermot J Murphy, Siba El Hussein, Angela Applebee, et al.
CNS Oncology|February 2, 2018
Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumabAlissa Thomas, Marc Rosenblum, Sasan Karimi, et al.
JAMA Neurology|October 30, 2013
Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapyAlissa Thomas, Paula Rauschkolb, Núria Gresa-Arribas, et al.
Neuro-Oncology|November 6, 2015
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patientsMyron Zhang, Bryanna Gulotta, Alissa Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Pageof 1